Post Inflammatory Hyperpigmentation Completed Phase Trials for Clobetasol propionate (DB01013)

Also known as: Post inflammatory pigmentation change / Postinflammatory hyperpigmentation

IndicationStatusPhase
DBCOND0045798 (Post Inflammatory Hyperpigmentation)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02492373Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG LaserTreatment